QUINNsNextStep

Nektar Range for 3/2020

看多
NASDAQ:NKTR   Nektar Therapeutics
Earnings beat yesterday with positive mobility in R&D, plus the regulatory committee has resumed inquiries that were previously placed on hold.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。